Welcome to our dedicated page for Pyrophyte Acquisition II SEC filings (Ticker: PAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. regulatory filing information for Pyrophyte Acquisition Corp. II (NYSE: PAII), a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company has indicated an expected focus on targets in the energy sector, although it may consider opportunities in other areas.
For a SPAC such as Pyrophyte Acquisition Corp. II, SEC filings are central to understanding its structure, financing, and progress toward a potential business combination. Key documents include the registration statement that was declared effective by the U.S. Securities and Exchange Commission in connection with its initial public offering, as referenced in the company’s news releases. That registration statement and related prospectus describe the terms of the units, the Class A ordinary shares, the redeemable warrants, the private placement warrants purchased by the sponsor, and the trust account that holds the offering proceeds.
Through this page, users can review the company’s historical and future filings as they become available on EDGAR, such as annual and quarterly reports, proxy materials related to any proposed business combination, and other disclosure documents. These filings typically explain how the trust account is structured, the conditions under which funds may be released, and the procedures for completing a business combination or returning funds to public shareholders if no transaction is completed.
Stock Titan enhances this information with AI-powered summaries that are designed to make lengthy and technical filings easier to understand. As filings for Pyrophyte Acquisition Corp. II appear, the platform highlights important terms related to its SPAC structure, warrant features, and any proposed business combination, helping readers navigate complex regulatory language more efficiently.
Pyrophyte Acquisition Corp. II received a Schedule 13G reporting that its sponsor, Pyrophyte Acquisition II LLC, together with managing members Sten Gustafson and Bernard Duroc‑Danner, beneficially owns 7,135,721 Class B ordinary shares. These Class B shares are convertible into Class A ordinary shares and represent 26.2% of the company’s ordinary share classes.
The filing states that the sponsor directly holds the securities, while the two managing members control sole voting and dispositive power through the sponsor and may be deemed beneficial owners. The disclosure also notes 5,050,000 private placement warrants that could become exercisable for an equal number of Class A shares, which are excluded from the reported ownership.
Millennium Management LLC and related parties report a 3.9% passive stake in Pyrophyte Acquisition Corp. II. They beneficially own 775,000 Class A ordinary shares, with shared voting and dispositive power over all of these shares and no sole voting or dispositive authority.
The shares are held through entities over which Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander exercise voting control or investment discretion. The filers state the securities were not acquired and are not held to change or influence control of Pyrophyte.
Pyrophyte Acquisition Corp. II (PAII) filed its Q3 report, highlighting its post‑IPO SPAC status and capital position. The company completed its IPO and a partial over‑allotment, placing $200,411,500 into a U.S. trust account and reporting trust assets of $202,044,257 as of September 30, 2025. Net income for the quarter was $1,437,769, driven primarily by interest on trust investments, while general and administrative expenses were $195,104.
PAII sold 20,041,150 units at $10.00 per unit, each with one Class A share and one‑half warrant; private placement warrants totaled 5,050,000 at a $1.00 price. Deferred underwriting fees are $9,399,690. Cash outside the trust was $721,227 at quarter‑end to fund ongoing SPAC operating needs.
Public shareholders may redeem Class A shares in connection with an initial business combination or if no deal is completed within 24 months from the IPO closing. As of November 14, 2025, 20,041,150 Class A and 7,225,721 Class B ordinary shares were outstanding.
Pyrophyte Acquisition Corp. II (PAII) received an Amendment No. 1 to Schedule 13G from Harraden Circle entities, reporting beneficial ownership of 0 shares and 0% of the Class A Common Stock. The event date is 09/30/2025.
The filing lists multiple Harraden-affiliated funds and control entities, all showing no sole or shared voting or dispositive power. The signatory certified the securities were not acquired or held to change or influence control, consistent with a passive Schedule 13G filing.
Pyrophyte Acquisition Corp. II Schedule 13G discloses that Linden-related entities and Siu Min (Joe) Wong beneficially own between 1,101,657 and 1,150,000 Class A ordinary shares as of September 16, 2025. Those holdings represent approximately 5.5% (Linden GP and Linden Capital) and 5.7% (Linden Advisors and Mr. Wong) of the 20,041,150 shares outstanding cited from the issuer's September 2, 2025 quarterly report. The filing states shared voting and dispositive power only, and includes a certification that the shares were not acquired to change or influence control of the issuer.